Table 1 Patient and tumour characteristics according to the type of radiotherapy (3D-CRT vs. IMRT/Tomotherapy)
From: Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis
3D-CRT | IMRT/Tomotherapy | |
|---|---|---|
Total number of patients | 37 (35.2%) | 68 (64.8%) |
Age [years] | ||
Median | 61 | 54 |
Range | 35 - 94 | 22 - 86 |
Sex | ||
Male | 1 (2.7%) | 13 (19.1%) |
Female | 36 (97.3%) | 55 (80.9%) |
T stage | ||
T1 | 9 (24.3%) | 11 (16.2%) |
T2 | 18 (48.7%) | 36 (52.9%) |
T3 | 6 (16.2%) | 13 (19.1%) |
T4 | 4 (10.8%) | 8 (11.8%) |
N stage | ||
N0 | 29 (78.4%) | 50 (73.5%) |
N1 | 1 (2.7%) | 8 (11.8%) |
N2 | 5 (13.5%) | 4 (5.9%) |
N3 | 2 (5.4%) | 6 (8.8%) |
M stage | ||
M0 | 37 (100%) | 66 (97.1%) |
M1 | 0 (0%) | 2 (2.9%) |
Histology | ||
Squamous cell | 35 (94.6%) | 65 (95.6%) |
Other (small cell, basaloid) | 2 (5.4%) | 3 (4.4%) |